Stada urges shareholders to accept Bain, Cinven bid
May 12, 2017
Drug Discovery | Bad Vilbel, Germany | Buyout
The executive and supervisory boards of pharmaceuticals company Stada (FRA: SAZ) have recommended that shareholders accept a €5.3 billion takeover offer from Bain Capital and Cinven. The pair of PE firms won the auction for the company last month, after Stada opened up the bidding process in February.